Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$5.07 - $7.2 $75,036 - $106,560
-14,800 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$5.67 - $8.54 $548,890 - $826,723
-96,806 Reduced 86.74%
14,800 $95,000
Q3 2021

Nov 04, 2021

BUY
$13.4 - $16.3 $121,538 - $147,841
9,070 Added 8.85%
111,606 $1.54 Million
Q2 2021

Jul 19, 2021

BUY
$14.81 - $19.13 $694,589 - $897,197
46,900 Added 84.3%
102,536 $1.52 Million
Q1 2021

May 17, 2021

BUY
$14.52 - $23.53 $684,138 - $1.11 Million
47,117 Added 553.08%
55,636 $990,000
Q1 2021

May 14, 2021

SELL
$14.52 - $23.53 $697,816 - $1.13 Million
-48,059 Reduced 84.94%
8,519 $1.19 Million
Q4 2020

Feb 16, 2021

BUY
$10.14 - $15.19 $573,700 - $859,419
56,578 New
56,578 $808,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $617M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Woodward Diversified Capital, LLC Portfolio

Follow Woodward Diversified Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodward Diversified Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Woodward Diversified Capital, LLC with notifications on news.